Study: SPECT sheds light on liver function, may aid cancer treatment

02/9/2013 | MedicalXpress.com

SPECT imaging with 99mTc-labeled iminodiacetic acid before and during radiation therapy to monitor hepatic function in patients with unresectable liver cancer provides data that could allow for more personalized treatment plans, according to a study presented at an imaging and radiation therapy conference. "The physiological adaptation of radiation therapy based upon individual response assessment is a valuable new paradigm worth additional testing," said lead researcher Hesheng Wang of the University of Michigan.

View Full Article in:

MedicalXpress.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI